RecallRadar

FDA Drug recall D-0218-2017

Bupivacaine Hydrochloride Inj., USP (2.5 mg/mL) 0.25%, packaged in 30 mL Single-dose Preservative-Free vials, Rx Only, Hospira, Inc., Lake…

On 2016-12-28 the FDA classified a Class I recall of Bupivacaine Hydrochloride Inj., USP (2.5 mg/mL) 0.25%, packaged in 30 mL Single-dose Preservative-Free vials, Rx Only, Hospira, Inc., Lake… by Hospira A Pfizer, citing presence of particulate matter: Confirmed customer report for the presence of particulate matter within a single vial.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0218-2017
ClassificationClass I
Statusongoing
Initiated2016-08-04
Published2016-12-28
Last updated2026-09-13 11:51 UTC
CompanyHospira A Pfizer
DistributionUS

Product

Bupivacaine Hydrochloride Inj., USP (2.5 mg/mL) 0.25%, packaged in 30 mL Single-dose Preservative-Free vials, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1159-02

Reason

Presence of particulate matter: Confirmed customer report for the presence of particulate matter within a single vial.

Identifiers

ndc0409-1159-18
ndc0409-1159-01
ndc0409-1159-19
ndc0409-1159-02
ndc0409-1160-18
ndc0409-1160-01
ndc0409-1162-18
ndc0409-1162-01
ndc0409-1162-19
ndc0409-1162-02
ndc0409-1163-18
ndc0409-1163-01
ndc0409-1165-18
ndc0409-1165-01
ndc0409-1165-19
ndc0409-1165-02
ndc0409-9043-11
ndc0409-9043-01
ndc0409-9046-11
ndc0409-9046-01
ndc0409-9045-11
ndc0409-9045-01
ndc0409-9045-16
ndc0409-9045-17
ndc0409-9042-11
ndc0409-9042-01
ndc0409-9042-16
ndc0409-9042-17
code_infoLot # 59064DK, Exp. 11/17

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0218-2017%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.